BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 22948665)

  • 1. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
    [No Abstract]   [Full Text] [Related]  

  • 4. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-titin antibodies are not associated with a specific thymoma histology.
    Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance.
    Aarli JA; Skeie GO; Mygland A; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():505-15. PubMed ID: 9668283
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients.
    Yamamoto AM; Gajdos P; Eymard B; Tranchant C; Warter JM; Gomez L; Bourquin C; Bach JF; Garchon HJ
    Arch Neurol; 2001 Jun; 58(6):885-90. PubMed ID: 11405802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
    Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
    Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
    Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
    J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A striational muscle antigen and myasthenia gravis-associated thymomas share an acetylcholine-receptor epitope.
    Marx A; Osborn M; Tzartos S; Geuder KI; Schalke B; Nix W; Kirchner T; Müller-Hermelink HK
    Dev Immunol; 1992; 2(2):77-84. PubMed ID: 1379503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma.
    Fujii Y; Monden Y; Nakahara K; Hashimoto J; Kawashima Y
    Neurology; 1984 Sep; 34(9):1182-6. PubMed ID: 6611521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titin, thymoma, and myasthenia gravis.
    Aarli JA
    Arch Neurol; 2001 Jun; 58(6):869-70. PubMed ID: 11405799
    [No Abstract]   [Full Text] [Related]  

  • 20. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.
    Berrih-Aknin S; Le Panse R
    J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.